Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 5/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.30 |
| ▸ | PYGL | P06737 | 1/20 | 0.30 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | GLB1 | P16278 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.30 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11114570 | 0.79 | CYP1A2 (0.41) | CYP1A2CYP2D6TDP1 | |
| SCHEMBL811603 | 0.78 | CYP1A2 (0.34) | CYP1A2CYP2D6TDP1 | |
| SCHEMBL2379725 | 0.75 | CYP1A2 (0.49) | CYP1A2CYP2D6TDP1APOBEC3AAPOBEC3G | |
| SCHEMBL13021351 | 0.75 | CYP1A2 (0.44) | CYP1A2CYP2D6TDP1APOBEC3AAPOBEC3G | |
| SCHEMBL7735125 | 0.75 | CYP1A2 (0.49) | CYP1A2CYP2D6TDP1APOBEC3AAPOBEC3G | |
| SCHEMBL23524459 | 0.74 | CYP1A2 (0.34) | CYP1A2CYP2D6 | |
| SCHEMBL899404 | 0.73 | TDP1 (0.39) | GBA1TDP1APOBEC3AAPOBEC3G | |
| SCHEMBL21283415 | 0.72 | SI (0.42) | GBA1CYP1A2CYP2D6TDP1SI | |
| SCHEMBL810971 | 0.72 | CA1 (0.36) | CTDSP1KDM4EAPOBEC3AAPOBEC3G | |
| SCHEMBL13658057 | 0.71 | CYP1A2 (0.42) | CYP1A2CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2621995-B1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-03-23 | — | — | EP | disclosed |
| US-9284434-B2 | Epoxy resin compositions | BLUE CUBE IP LLC (US) | 2016-03-15 | — | — | US | disclosed |
| EP-2621990-B1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | BLUE CUBE IP LLC (US) | 2016-02-24 | — | — | EP | disclosed |
| CN-103124757-B | Advanced composition epoxy resin | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-11-25 | — | — | CN | disclosed |
| WO-2015148039-A1 | PARTIALLY HYDROLYZED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-10-01 | — | — | WO | disclosed |
| US-9068039-B2 | Thermosettable compositions and thermosets therefrom | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-06-30 | — | — | US | disclosed |
| US-20150152285-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | BLUE CUBE IP LLC | 2015-06-04 | — | — | US | disclosed |
| US-20140194554-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-07-10 | — | — | US | disclosed |
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | UCB PHARMA S.A. (BE) | 2013-11-14 | — | — | US | disclosed |
| US-20130237642-A1 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-09-12 | — | — | US | disclosed |
| EP-2621994-A1 | EPOXY RESIN COMPOSITIONS | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| EP-2621990-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | Dow Global Technologies LLC (US) | 2013-08-07 | — | — | EP | disclosed |
| US-20130178591-A1 | ADVANCED POLY EPOXY ESTER RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-11 | — | — | US | disclosed |
| US-20130178590-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-11 | — | — | US | disclosed |
| CN-103124757-A | Advanced epoxy resin compositions | DOW GLOBAL TECHNOLOGIES LLC | 2013-05-29 | — | — | CN | disclosed |
| CN-103124758-A | Advanced poly epoxy ester resin compositions | DOW GLOBAL TECHNOLOGIES LLC | 2013-05-29 | — | — | CN | disclosed |
| WO-2012050777-A1 | ADVANCED POLY EPOXY ESTER RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-19 | — | — | WO | disclosed |
| WO-2012047420-A2 | THERMOSETTABLE COMPOSITIONS AND THERMOSETS THEREFROM | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-12 | — | — | WO | disclosed |
| WO-2012044443-A1 | EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2012044458-A1 | ADVANCED EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-04-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130302336-A1 | DISULFIDE STABILIZED DVD-IG MOLECULES | EED, DRD2, PSMD14 | GBA1 3924/4885CYP1A2 2559/4885CYP2D6 1316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.